申请人:Merck Sharp & Dohme Corp
公开号:US07834036B2
公开(公告)日:2010-11-16
Fused aromatic compounds of Formula (I) are PPAR gamma agonists or partial agonists and are useful in the treatment or control of type II diabetes, including hyperglycemia, dyslipidermia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes.
式(I)的融合芳香化合物是PPAR gamma激动剂或部分激动剂,可用于治疗或控制II型糖尿病,包括常伴随II型糖尿病的高血糖、血脂异常、高脂血症、高胆固醇血症、高三酰甘油血症和肥胖症。